Skoczynska A, Oldakowska M, Dobosz A, Adamiec R, Gritskevich S, Jonkisz A
Biomolecules. 2024; 14(7).
PMID: 39062500
PMC: 11275227.
DOI: 10.3390/biom14070786.
Godoi A, do Canto A, Donatti A, Rosa D, Bruno D, Alvim M
Metabolites. 2022; 12(5).
PMID: 35629950
PMC: 9148034.
DOI: 10.3390/metabo12050446.
Maheshwari G, Ringseis R, Wen G, Gessner D, Rost J, Fraatz M
Biomolecules. 2020; 10(9).
PMID: 32878262
PMC: 7565516.
DOI: 10.3390/biom10091259.
Chandra S, Roy A, Patel D, Pahan K
J Alzheimers Dis. 2019; 71(2):389-397.
PMID: 31424405
PMC: 8163018.
DOI: 10.3233/JAD-190586.
Chandra S, Pahan K
J Alzheimers Dis Rep. 2019; 3(1):149-168.
PMID: 31259309
PMC: 6597963.
DOI: 10.3233/ADR-190104.
PPAR-gamma agonist pioglitazone modifies craving intensity and brain white matter integrity in patients with primary cocaine use disorder: a double-blind randomized controlled pilot trial.
Schmitz J, Green C, Hasan K, Vincent J, Suchting R, Weaver M
Addiction. 2017; 112(10):1861-1868.
PMID: 28498501
PMC: 5593771.
DOI: 10.1111/add.13868.
Role of peroxisome proliferator-activated receptors alpha and gamma in gastric ulcer: An overview of experimental evidences.
Saha L
World J Gastrointest Pharmacol Ther. 2015; 6(4):120-6.
PMID: 26558146
PMC: 4635152.
DOI: 10.4292/wjgpt.v6.i4.120.
Central mechanisms mediating the hypophagic effects of oleoylethanolamide and N-acylphosphatidylethanolamines: different lipid signals?.
Romano A, Tempesta B, Provensi G, Passani M, Gaetani S
Front Pharmacol. 2015; 6:137.
PMID: 26167152
PMC: 4481858.
DOI: 10.3389/fphar.2015.00137.
Anti-kindling Effect of Bezafibrate, a Peroxisome Proliferator-activated Receptors Alpha Agonist, in Pentylenetetrazole Induced Kindling Seizure Model.
Saha L, Bhandari S, Bhatia A, Banerjee D, Chakrabarti A
J Epilepsy Res. 2015; 4(2):45-54.
PMID: 25625088
PMC: 4295053.
DOI: 10.14581/jer.14011.
Effects of lipid-lowering pharmaceutical clofibrate on lipid and lipoprotein metabolism of grass carp (Ctenopharyngodon idellal Val.) fed with the high non-protein energy diets.
Guo X, Liang X, Fang L, Yuan X, Zhou Y, He S
Fish Physiol Biochem. 2014; 41(2):331-43.
PMID: 25213789
DOI: 10.1007/s10695-014-9986-8.
Does Pro(12)Ala Polymorphism Enhance the Physiological Role of PPARγ2?.
Pereira A, Oliveira R, Castro A, Fernandes R
PPAR Res. 2013; 2013:401274.
PMID: 23983677
PMC: 3747383.
DOI: 10.1155/2013/401274.
The role of peroxisome proliferator-activated receptors in the esophageal, gastric, and colorectal cancer.
Fucci A, Colangelo T, Votino C, Pancione M, Sabatino L, Colantuoni V
PPAR Res. 2012; 2012:242498.
PMID: 22991505
PMC: 3444044.
DOI: 10.1155/2012/242498.
Overcoming challenges of ovarian cancer stem cells: novel therapeutic approaches.
Aguilar-Gallardo C, Rutledge E, Martinez-Arroyo A, Hidalgo J, Domingo S, Simon C
Stem Cell Rev Rep. 2012; 8(3):994-1010.
PMID: 22278130
DOI: 10.1007/s12015-011-9344-5.
Therapeutic potential of peroxisome proliferator-activated receptors in chronic inflammation and colorectal cancer.
Wang D, DuBois R
Gastroenterol Clin North Am. 2010; 39(3):697-707.
PMID: 20951925
PMC: 2957674.
DOI: 10.1016/j.gtc.2010.08.014.
PPARalpha-dependent activation of cell cycle control and DNA repair genes in hepatic nonparenchymal cells.
Qu A, Shah Y, Matsubara T, Yang Q, Gonzalez F
Toxicol Sci. 2010; 118(2):404-10.
PMID: 20813756
PMC: 2984533.
DOI: 10.1093/toxsci/kfq259.
PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors.
Benedetti E, Galzio R, DAngelo B, Ceru M, Cimini A
PPAR Res. 2010; 2010:427401.
PMID: 20339586
PMC: 2841252.
DOI: 10.1155/2010/427401.
Peroxisome-proliferator-activated receptors γ and β/δ mediate vascular endothelial growth factor production in colorectal tumor cells.
Rohrl C, Kaindl U, Koneczny I, Hudec X, Baron D, Konig J
J Cancer Res Clin Oncol. 2010; 137(1):29-39.
PMID: 20221637
DOI: 10.1007/s00432-010-0856-1.
Activating peroxisome proliferator-activated receptor gamma mutant promotes tumor growth in vivo by enhancing angiogenesis.
Tian L, Zhou J, Casimiro M, Liang B, Ojeifo J, Wang M
Cancer Res. 2009; 69(24):9236-44.
PMID: 19934321
PMC: 2794957.
DOI: 10.1158/0008-5472.CAN-09-2067.
Peroxisome Proliferator-Activated Receptors (PPARs) as Potential Inducers of Antineoplastic Effects in CNS Tumors.
Tatenhorst L, Hahnen E, Heneka M
PPAR Res. 2008; 2008:204514.
PMID: 18725982
PMC: 2517124.
DOI: 10.1155/2008/204514.
Activation of peroxisome proliferator-activated receptor alpha in human peripheral blood mononuclear cells reveals an individual gene expression profile response.
Bouwens M, Afman L, Muller M
BMC Genomics. 2008; 9:262.
PMID: 18518955
PMC: 2430976.
DOI: 10.1186/1471-2164-9-262.